(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

COMPOSIÇÃO DE MATRIZ COMPREENDENDO (S)-5-BENZIL-N-(5- METIL-4-OXO-2,3,4,5-TETRAHIDROBENZO[B][1,4]OXAZEPIN-3-IL)-4H-1,2,4- TRIAZOL-3-CARBOXAMIDA

ArquivadaInvention PatentPCT · IB2020054615

Application data

Number

112021023040

Type

Invention Patent

Filing

05/15/2020

Publication

12/28/2021

PCT

IB2020054615

Progress at the INPI

  1. Filing05/15/20
  2. Publication12/28/21
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: examination was not requested within the 36 months following the 05/15/2020 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 09/26/2023. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED

GB

See this company's full portfolio

Inventors

R. A. (pessoa física)

US

R. P. (pessoa física)

US

X. C. (pessoa física)

US

Technical data

Priority claims

US

62/849,180 · 05/17/2019

US

62/990,093 · 03/16/2020

Abstract

COMPOSIÇÃO DE MATRIZ COMPREENDENDO (S)-5-BENZIL-N-(5- METIL-4-OXO-2,3,4,5-TETRAHIDROBENZO[B][1,4]OXAZEPIN-3-IL)-4H-1,2,4- TRIAZOL-3-CARBOXAMIDA. A presente invenção refere-se a composições farmacêuticas de liberação modificada de um composto inibidor de quinase RIP1 e formas do mesmo, processos ou métodos de preparação de composição e seus usos ou métodos de tratamento.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento definitivo - Art. 33 da LPI

#11.1.1

09/26/2023

RPI 2751

Arquivamento - Art. 33 da LPI

#11.1

07/11/2023

RPI 2740

Notificação de entrada na fase nacional - PCT

#1.3

12/28/2021

RPI 2660

Alteração de dados cadastrais

#1.1

11/30/2021

RPI 2656

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.